Annual General Meeting of Endomines AB (publ) on April 24,

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Apr 25, 2014 at 3:00 AM

Annual General Meeting of Endomines AB (publ) on April 24, 2014

The Annual General Meeting (the “AGM”) of shareholders of Endomines AB (publ) was held on April 24, 2014. Appropriation of Endomines AB’s loss and discharge from liability for members of the Board of Directors and the CEO The AGM resolved to adopt the Profit and Loss Statement and the Balance Sheet for the Parent Company as well as the Consolidated Profit and Loss Statement and the Consolidated Balance Sheet for the Group for 2013. The AGM resolved that no dividend should be paid and that the company's profits be disposed of such that SEK 60,968,113 be carried forward to new account, consisting of share premium reserve of SEK 172,523,683, retained losses of SEK 87,017,264 and this year's loss of SEK 24,538,306. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2013. Board of Directors The AGM resolved that the Board of Directors should consist of five members. Staffan Simberg, Meg Tivéus, Stefan Månsson, Rauno Pitkänen and Mati Sallert were re-elected as members of the Board of Directors. In addition Staffan Simberg was re-elected as chairman of the Board. Timo Lindborg has declined re -election. The AGM further resolved that the yearly fees shall be SEK 250,000 to the chairman of the Board of Directors and SEK 150,000 to each of the non-employed members of the Board. It was further resolved that Committee work fees shall be SEK 25,000 to each member of the remuneration committee, audit committee and technical and security committee and SEK 50,000 to the chairman of the audit committee. The Nomination Committee The AGM approved the proposal for a Nomination Committee for the AGM 2015 and that it shall consist of three members, of which two shall represent the two larger shareholders and the third shall be the chairman of the Board of Directors. The chairman of the Board of Directors shall during the autumn 2014 contact the larger shareholders as per 31 August 2014 to establish a Nomination Committee. The shareholders, which at such point in time, holds the largest numbers of votes shall have the right to appoint one representative each to, next to the chairman of the Boards of Directors, form the Nominations Committee until the next AGM. Guidelines for remuneration to senior executives The AGM also resolved to approve to Board of Directors' proposal for guidelines for remuneration to senior executives. Authorization for the Board of Directors to resolve on a new issue of shares The AGM resolved to authorize the Board of Directors during the period up to the next Annual General Meeting to resolve on the issuance of shares and/or convertibles, with deviation from the shareholders' preemption right. By resolution pursuant to the authorization, the number of new shares that can be issued may, in aggregate, be equivalent to the number of shares corresponding to maximum 10 per cent of the total number of existing shares in Endomines at the time of registration of the share issue authorization. For further information please contact: Markus Ekberg, CEO of Endomines AB, tel. +358 40 706 48 50 Staffan Simberg, Chairman of the Board of Endomines AB, tel. +358 50 020 92 16 ________________________________________________________________________________ _ _______ Endomines AB discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at 08:45 CET on 25 April, 2014. About Endomines AB Endomines AB is a Nordic mining and exploration company with its first operating gold mine in production since February 2011. The mine is located in Eastern Finland, on the Karelian Gold Line, a 40 km long gold critical belt, where Endomines controls all currently known gold deposits. The company’s business practices and mining operations are based on sustainable principles and on minimizing the impact on the environment. Endomines applies SveMin's&FinnMin's respective rules for reporting (public mining & exploration companies). It has chosen to report mineral resources and ore reserves according to the JORC-code, which is the internationally accepted Australasian code for reporting ore reserves and mineral resources. The shares of Endomines AB are quoted on NASDAQ OMX Stockholm under ticker ENDO.ST. Pareto Öhman acts as Liquidity Provider in Stockholm. Read more about Endomines on www.endomines.com

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quest Diagnostics at Jefferies Conference: What’s Next?

Quest Diagnostics Set for the Spotlight in London You're sipping your morning coffee when you hear that Quest Diagnostics (NYSE: DGX) is gearing up for a fireside chat in the UK's capital. Now, this isn't a random chit-chat we're talking about. Sam Samad, the man handling the books as their CFO, will be chatting it up at the Jefferies Global Healthcare Conference on...

Greenberg Traurig Expands Franchise Team with Tuneski

DC’s Legal Landscape Shifts with Tuneski’s Move Greenberg Traurig's Washington, D.C., office just dialed it up a notch by bringing in Alexander Tuneski. A guy like this crossing the floor from DLA Piper is big news. This isn’t just any legal bean counter; with over 20 years under his belt, Tuneski knows franchise law like the back of his hand. And when you've been...

Envision and ju:niz Boost Germany's Energy Storage

Germany Charges Ahead with Renewable Energy Storage Germany's on a mission, folks, and it's all about beefing up their renewable energy infrastructure. Out in Bavaria, Envision Energy and ju:niz Energy are prepping a significant leap forward. They're rolling out a big undertaking—a 442 MWh battery energy storage system (BESS) with their Smareg 13 project in Vöhringen....

Paul Taubman Takes Helm at Cold Spring Harbor Lab

Paul Taubman Steers the Ship at CSHL Here's the buzz coming out of Cold Spring Harbor Lab: they're handing the reins over to Paul Taubman. It's like swapping captains in the middle of the ocean—big shoes need to stay afloat. This place isn't just the playground for science nerds; it's a powerhouse in biomedical research. Now, we've got Taubman, a fella who's been...

Deadline Looms for BETR Investors: Take Action Now

What’s the Fuss About? Alright folks, let’s lay this out simple: Better Home & Finance Holding Company (NASDAQ: BETR) is in hot water. A class action’s been slapped on them, accusing the firm of sugarcoating its business prospects. If you bought BETR shares between March 13, 2026, and May 7, 2026, you might have a dog in this fight. Buckle up, because the stakes are...

Summit Midstream's Q3 Financial Results Signal Growth

Summit Midstream Delivers Strong Q3 Results Good grief, you'd think the grease is sliding off the griddle with these numbers. Summit Midstream Corporation (NYSE:SMC) is putting up figures that ought to make even the most poker-faced of traders crack a smile. We've got a net income sitting pretty at $15.9 million, and an Adjusted EBITDA that's climbed up to $70.7 million....

New Metrics Aim to Elevate Organ Procurement Performance

Revamping Organ Procurement: A New Approach In the tangled web of healthcare, the organ donation system stands as a lifeline that's often tangled in its metrics. The latest stride by the Association of Organ Procurement Organizations (AOPO) might put some untethered efforts in line. With an announcement on November 9, 2026, the AOPO unveiled three fresh performance...

Bimbo Bakeries Teamsters Gear Up for Strike in NJ

A Brewing Storm at Bimbo Bakeries The morning air in East Brunswick fills with more than just the scent of fresh bread; there’s a tension you can slice through with a butter knife. Unwavering and fired-up, over 90 workers at Bimbo Bakeries have thrown their hats into the ring, ready to strike to protect something as sacred as the dough they churn—Teamsters' health...

Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Specialty1 Partners: Top Workplaces Triumph in 2026

Employees Crown Specialty1 Partners a Workplace Gem There are only a few things in the business world sweeter than being named a Top Workplace, and flying that banner proudly is exactly what Specialty1 Partners gets to do. Named a winner by the Houston Chronicle in 2026, this recognition is no regular accolade. It's built on the raw honesty that employee surveys provide,...